PMC:7755033 / 91111-91338
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1706 | 35-37 | Species | denotes | WS | Tax:126910 |
| 1707 | 102-110 | Chemical | denotes | Losartan | |
| 1708 | 112-124 | Chemical | denotes | Procainamide | MESH:D011342 |
| 1709 | 126-136 | Chemical | denotes | Cinacalcet | MESH:D000069449 |
| 1710 | 138-145 | Chemical | denotes | Arbidol | MESH:C086979 |
| 1711 | 147-165 | Chemical | denotes | Hydroxychloroquine | MESH:D006886 |
| 1712 | 167-177 | Chemical | denotes | Oberadilol | |
| 1713 | 179-189 | Chemical | denotes | Poziotinib | MESH:C557213 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T932 | 0-227 | Sentence | denotes | PCA of physiological properties of WS phytoconstituents versus FDA–approved standard reference drugs (Losartan, Procainamide, Cinacalcet, Arbidol, Hydroxychloroquine, Oberadilol, Poziotinib). (A) Scatter Plot (B) 3D Point Plot. |